General Purpose
Terminated 5/21/2015
ID: 1307363
·
First filed: May 28, 2008
Baybio Pac, Sponsored By the Bay Area Bioscience Association
View
Receipt Summary
| Source Type | Distribution | Amount | Percentage |
|---|---|---|---|
| Other | $200K | 89.6% | |
| Individual | $19.8K | 8.8% | |
| Committee | $3.53K | 1.6% | |
| Total | $223K | 100% |
Receipts
| Donor | Total Amount | % of Total | |
|---|---|---|---|
|
Cepheid
Other
|
0.3% | ||
|
The Column Group, Llc
Other
|
0.3% | ||
|
Francisco D. Salva
|
0.2% | ||
|
Sangamo Biosciences via Baybio
Other
|
0.2% | ||
|
Exelixis Inc. Via Baybio
Other
|
0.2% | ||
|
Wareham Development Corp.
Other
|
0.2% | ||
|
Jazz Pharmaceuticals via Baybio
Other
|
0.2% | ||
|
Complete Genomics Inc. Via Baybio
Other
|
0.2% | ||
|
Medivation via Baybio
Other
|
0.2% | ||
|
Intermune via Baybio
Other
|
0.2% | ||
|
A. Franklin Rice
Evp Finance, Administration And Director at Vista Gen Therapeutics, Inc
|
0.2% | ||
|
Lynn Pasahow
Attorney at Fenwick And West, Llp
|
0.2% | ||
|
Analysis Group, Inc.
Other
|
0.2% | ||
|
Oculus Innovative Sciences via Baybio
Other
|
0.2% | ||
|
Evotec Inc. Via Baybio
Other
|
0.2% | ||
|
Allcells Inc. Via Baybio
Other
|
0.2% | ||
|
Facet Biotech
Other
|
0.2% | ||
|
Sangamo Biosciences, Inc.
Committee
|
0.2% | ||
|
Xdx, Inc.
Other
|
0.2% | ||
|
Complete Genomics, Inc.
Other
|
0.2% | ||
|
Alexza Pharmaceuticals
Other
|
0.2% | ||
|
Mendel Biotechnology
Other
|
0.2% | ||
|
Onyx Pharmaceuticals, Inc.
Other
|
0.2% | ||
|
Genomic Health, Inc.
Other
|
0.2% | ||
|
Theravance, Inc.
Other
|
0.2% |